Novel therapeutic agents for macromolecular structures
CA 2319085 A1 · Owner: Theravance, Inc. · Inventors: Moran, Edmund J.; Griffin, John H.; Oare, David
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are novel multibinding compounds (agents) which bind macromolecular structures including cellular, extracellular and microbial components derived , from vectors viruses, fungi, yeasts, bacteria, and the like. The compounds of this invention comprise a plurality of ligands each of which can bind to such macromolecular structures thereby modulating the biological processes/functions thereof. Each of the ligands is covalently attached to a linker (framework) to provide for the multibinding compound. The linker is selected such that the multibinding compound so constructed demonstrates increased modulation or disruption of the biological processes/functions of cell as compared …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 7, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 7, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 7, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.